Financial results - MIDOCRIN SRL

Financial Summary - Midocrin Srl
Unique identification code: 16730893
Registration number: J13/7439/2004
Nace: 6920
Sales - Ron
224.160
Net Profit - Ron
158.168
Employees
1
Open Account
Company Midocrin Srl with Fiscal Code 16730893 recorded a turnover of 2025 of 224.160, with a net profit of 158.168 and having an average number of employees of 1. The company operates in the field of Activităţi de contabilitate şi audit financiar; consultanţă în domeniul fiscal having the NACE code 6920.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Midocrin Srl

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Sales - EUR 7.771 11.723 13.603 12.159 13.090 20.506 22.790 37.128 38.822 224.160
Total Income - EUR 7.771 11.733 13.741 12.159 13.090 20.506 24.753 37.128 38.822 231.929
Total Expenses - EUR 1.473 1.737 2.089 2.367 3.077 2.319 3.265 10.461 12.555 71.523
Gross Profit/Loss - EUR 6.299 9.995 11.652 9.792 10.013 18.187 21.488 26.668 26.266 160.406
Net Profit/Loss - EUR 6.066 9.643 11.240 9.427 9.620 17.584 20.804 26.296 25.878 158.168
Employees 0 0 0 0 0 0 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 16.1%, from 38.822 euro in the year 2024, to 224.160 euro in 2025. The Net Profit increased by 29.442 euro, from 25.878 euro in 2024, to 158.168 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Midocrin Srl

Rating financiar

Financial Rating -
MIDOCRIN SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Midocrin Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Midocrin Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Midocrin Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Midocrin Srl - CUI 16730893

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Fixed Assets 0 0 0 0 701 590 1.002 432 154 2.663
Current Assets 6.848 14.811 20.391 20.026 15.115 17.197 22.115 26.337 34.245 165.286
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 551 2.156 1.934 1.623 2.309 2.450 2.072 2.438 2.963 32.151
Cash 6.297 12.654 18.457 18.403 12.806 14.748 20.043 23.900 9.168 33.135
Shareholders Funds 6.119 9.696 11.292 9.478 9.670 17.633 20.853 26.344 25.926 158.408
Social Capital 45 44 43 42 41 40 41 40 40 200
Debts 729 5.115 9.100 10.548 6.147 155 2.264 425 8.472 9.541
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 1 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908
Main CAEN "6920 - 6920"
CAEN Financial Year 6920
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 165.286 euro in 2025 which includes Inventories of 0 euro, Receivables of 32.151 euro and cash availability of 33.135 euro.
The company's Equity was valued at 158.408 euro, while total Liabilities amounted to 9.541 euro. Equity increased by 29.442 euro, from 25.926 euro in 2024, to 158.408 in 2025.

Risk Reports Prices

Reviews - Midocrin Srl

Comments - Midocrin Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.